Download 3. The post: Locum Consultant in Medical Oncology

yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Breast Cancer
Job Description
Job Plan
Person Specification
1. The Christie NHS Foundation Trust
The Christie Hospital and Holt Radium Institute was founded in 1932 and has grown to be the largest
Cancer Hospital in the UK and one of the largest Cancer Centres in Europe covering a large
population in North West England. The Trust is a designated teaching hospital of the University of
Manchester and is the focal point of the Regional Cancer Network. All cancer related specialties are
fully operational and more than 12,000 new patients with cancer are seen each year. It is a major
Cancer research centre and combined with the Paterson Institute and University of Manchester
comprises the Manchester Cancer Research Centre.
The Christie is composed of three clinical management divisions:
Networked Services Division – Director,, Dr Nick Slevin – includes the Departments of Medical
Oncology, Clinical Oncology, Palliative Care, Paediatric and Adolescent Oncology
Cancer Centre Services – Director, Prof. Peter Trainer - Surgery, Haematology, Anaesthetics, HDU,
Clinical Support Services – Director, Dr Jeremy Lawrence - Radiology, Pathology. Pharmacy,
Supportive care
Other support services are provided by the Corporate services Division including Finance, Nursing &
Governance, and Estates and Facilities.
Both the Departments of Medical Oncology (Director: Dr Mike Leahy) and Clinical Oncology (Director:
Dr John Logue), have international reputations for their clinical work. All consultants are site
specialised and common treatment policies are developed through the multi-disciplinary Disease
Groups (DGs). Links to the cancer units are maintained through a number of peripheral and outreach
clinics across the network. A radiotherapy satellite centre opens at Royal Oldham hospital in March
2010 with 2 linacs and facilities for outpatient oncology services. In addition, a radiotherapy centre at
Salford opens in 2011.
The present Executive Directors of the Trust are:
Caroline Shaw
Chief Executive
Ian Moston
Director of Finance & Business Development
Dr Chris Harrison
Medical Director
Alison Norman
Director of Nursing & Governance
Roger Spencer
Chief Operating Officer
2. Other Partner Institutions
University of Manchester
The University became the largest single site University in the UK in 2005 with the merger of the
Victoria University of Manchester and the University of Manchester Institute of Science and
Technology (UMIST). Approximately 50th in the world rankings, it has an ambitious programme of
development to become one of the top 25 universities in the world by 2015. Development is occurring
University wide and cancer is one of two areas selected for rapid development. It has significant
existing activities in cancer research within the Faculties of Medical and Human Sciences and Life
Sciences. This has been enhanced by the recent transfer merger of the Paterson Institute for Cancer
Research within the University.
Salford Royal NHS Foundation Trust
Salford Royal NHS Foundation Trust was licensed as a Foundation Trust from August 2006. It is a
teaching hospital with 870 beds and provides District Hospital services for Salford. It is also a subregional centre for renal medicine, immunology, neurosciences and neonatal intensive care and there
are many other highly specialised facilities including interventional radiology, intestinal failure, pain
management, dermatology, urology, orthopaedics and rheumatology.
The Trust is a teaching hospital for the University of Manchester Medical School and has an
established Research and Development programme.
Salford is the site of a major initiative and investment called the ‘SHIFT’ project (Salford Health
Investment For Tomorrow) This project spans primary and secondary care and will involve novel
modes of working and major investment in both primary and secondary care. On the hospital site this
involved a PFI scheme to redevelop facilities.
The Trust is a designated Associate Cancer Centre as outlined in the ‘Harrison’ Strategy for Greater
Manchester, and as such is the identified sector centre for Oesophagogastric, Urological,
Gynaecological and Haematology services. For these services it provides specialist services for the
populations of Ashton, Wigan and Leigh, Bolton and Salford PCT’s. The Trust hosts the specialist
services and MDT’s for Brain and Central Nervous system and Skin Cancers as well as providing a full
range of other local cancers services.
The Trust is working collaboratively with The Christie to develop satellite Radiotherapy services on the
Salford Royal site and to implement the Chemotherapy strategy.
The Trust Board comprised of the Executive Directors of the Trust and is responsible for the overall
performance of the Trust and delivery of its strategic and operational objectives. The following groups
feed into the Trust Board.
Strategy Advisory Group
Clinical effectiveness
Patient and Staff Experience
Risk Management
Finance and Performance
The Trust has a clinical governance strategy, which describes key roles and responsibilities for staff
providing services.
The present Executive Directors of the Trust are:
David Dalton
Chief Executive
Dr Stephen Waldek
Medical Director
Tony Whitfield
Director of Finance
Elaine Inglesby
Executive Nurse
Raj Jain
Director of Workforce and Corporate Affairs
Simon Neville
Director of Strategy and Development (and Executive lead for Cancer)
The Faculty of Medical and Human Sciences
The Faculty is large and comprehensive with all the important healthcare disciplines represented in
both research and teaching. Today, the Faculty has an annual research income of £51M, almost a
third of the University’s total research income. There are 7,600 undergraduate students and 1,600
post graduates on award-bearing courses. More students graduate each year from the School of
Medicine than from any other medical school in the UK.
The Faculty’s goal for 2015 is to be a world leader in the translation of key elements of biomedical
research to patient care, working in collaboration with the NHS and industrial partners.
The Greater Manchester Research Alliance (GMRA), brings the Faculty together with its six partner
teaching trusts and with other NHS trusts in the Greater Manchester region.
The Cancer and Imaging Sciences Research School in
the Faculty of Medical and Human Sciences
The focus for academic cancer medicine in the university is the Cancer and Imaging Sciences
Research School. With over 50 academic staff including 12 academic clinicians, the school currently
has approximately £11M per annum in research income. Interests span from biomarker studies using
clinical proteomics and microarray analyses to phase I/II/III clinical trials. The School has a first rate
publication record in high impact medicine and cancer journals.
The Paterson Institute for Cancer Research
The institute is a leading cancer research institute funded by CRUK. Research spans the whole
spectrum of cancer research, from programmes investigating the molecular and cellular basis of
cancer, to those focused on translational research and the development of novel therapeutic
The Cancer Research UK Department of Medical
Oncology at The Christie
The CRUK Department of Medical Oncology is now one of the largest departments of cancer medicine
in the UK. Professor Robert Hawkins is Director of Medical Oncology and the major remit of the
department is to develop improved methods for cancer patient management. There are both clinical
and laboratory scientific research components that are closely integrated with clinical research and
service work.
The Department is based at the Christie Cancer Centre (Christie Hospital and Paterson Institute for
Cancer Research) with a Breast Cancer Unit at Wythenshawe / Withington Hospital (University
Hospital of South Manchester NHS Foundation Trust) and a Thoracic Oncology Unit at Wythenshawe
Hospital (Cardiothoracic Centre). More than 2,500 new cancer patients are seen each year by staff in
the Department of Medical Oncology.
The Department has links with Preston Oncology Centre and with the Department of Medical
Oncology at Lancaster Royal Infirmary, which is included as part of the Medical Oncology SpR rotation
(total 17 NTNs).
The institute works in close collaboration with the neighbouring Christie NHS Foundation Trust and the
FHMS Cancer and Imaging Sciences Research School and is a partner in the newly formed
Manchester Cancer Research Centre.
3. The post: Locum Consultant in Medical Oncology
This is a locum consultant post, supported by the Greater Manchester and Cheshire Cancer Network
and The Christie NHS Foundation Trust.
The appointee will join one of the countries largest departments of Medical Oncology, which provides
comprehensive medical oncology services to patients with all forms of cancer both common and rare.
The Consultants in Medical Oncology are responsible for seeing new referrals, treatment
appointments and follow-ups in outpatients and taking full responsibility for the patients admitted under
their care to the wards. Consultants have the responsibility for managing their workload within their
agreed Job Plan including prioritisation of care for the patients referred to them.
Typical expected caseload for consultants follows national benchmarks with an average new referral
target of 200 – 250 new patients and 1000 – 2000 treatment events.
Initial cancer site specific responsibilities are detailed in this job description but are subject to variation
depending on service pressures and changes in circumstance within the department.
Consultants are bound by the professional standards enshrined in Good Medical Care as described by
the Royal Colleges and by the General Medical Council. This includes an expectation to contribute to
and to drive clinical audit as it pertains to their own clinical service. It is preferable that candidates be
on the General Medical Council Specialist Register in Medical Oncology. The appointee will be
expected to take responsibility for service development within their own clinical field.
The post-holder will be expected to participate in appropriate CPD activities. The Trust supports the
requirements for continuing medical education as laid down by the Royal College of Physicians, and is
committed to continue providing time and financial support for these activities.
The post carries automatic membership of the Medical Staff Committee and the post-holder will be
expected to contribute to the general running of the clinical services at Christie through participation in
committees etc within the time allocated for supporting professional activities.
The Trust identifies teaching and training as essential core activities and the consultant will support
the educational agenda of the Trust wherever possible including offering training to undergraduate
medical students from University of Manchester Medical School and the junior doctors at Foundation
year and Specialty trainee level.
The Christie is a research centre of excellence and the post-holder will be expected to support the
research activities and encouraged to develop research within their own practice.
The post-holder will have office accommodation and the support of a secretary. The new Consultant
will have appropriate IT support, including internet access, and training will be provided.
Disease group and MDT team membership
3.2.1. Breast Subgroup & MDT
The successful post holder will provide a medical oncology service for Breast cancer patients at The
Christie , linking with the existing consultants specialising in breast cancer –Drs Anne Armstrong, Greg
Wilson and Sacha Howell.
Currently there are 2 middle grade doctors (SpRs or ST3 – 6) attached to the Breast team and the
post holder will take an equal role with the other Breast medical oncology consultants in supervising
these doctors and also the junior grade medical staff in clinic and on the ward in the care of their
The post holder will undertake out patient clinics and provide in patient care. They will work as part of
the multidisciplinary team (MDT) and be a key decision maker in the MDT meetings held at the
University Hospital of South Manchester (Wythenshawe Hospital).
The post holder will be expected to partake in supporting professional activities including audit and
teaching. There will be Supporting Programmed Activities (SPAs) allocated to the post-holder for the
above (see job plan). The post holder will be expected to attend medical oncology consultants’
meetings and Breast Disease Group meetings (both monthly).
4. Clinical Staff
Consultants in the department of Medical Oncology:
Dr Anne Armstrong
Breast cancer
Dr Fiona Blackhall
Lung Cancer
Dr Mike Braun
Lower GI cancer
Dr Andrew Clamp
Gynaecology & ovary cancer
Dr Jurjees Hassan
Colorectal and Ovarian cancer
Professor Robert Hawkins
Renal, Gastric and Immunotherapy Phase I Trials
Dr Sacha Howell
Breast Cancer
Professor Gordon Jayson
Ovarian Cancer and Phase I Trials
Dr Michael Leahy
Sarcoma, germ cell cancer and TYA
Dr Kim Linton
Dr Paul Lorigan
Melanoma and Lung Cancer
Dr Was Mansoor
Upper GI cancer
Dr Saifee Mullamitha
Lower GI cancer
Professor John Radford
Professor Malcolm Ranson
Clinical Pharmacology and Lung Cancer
Dr Yvonne Summers
Lung cancer
Dr Paul Taylor
Lung cancer
Professor Nick Thatcher
Lung cancer
Dr Fiona Thistlethwaite
Upper GI cancer
Dr Juan Valle
Colorectal, Hepatobiliary cancer
Dr Andrew Wardley
Breast cancer
Dr Greg Wilson
Breast and Colorectal Cancer
Dr Richar Hubner
There are at present ten Specialist Registrars, six SHO level posts. Two Specialty Doctors and a
number of Clinical Research Fellows also participate in clinical activities, in addition to their laboratory
research. There will be further posts developed as the Foundation programme rolls out.
Associated Departments
4.1.1. Clinical Oncology (Director - Dr John Logue)
Clinical Oncology has thirty one consultants and state of the art radiotherapy equipment along with a
major research centre - The Wade Centre (Director Dr John Logue). The Clinical Oncology Division
provides a service to Greater Manchester and North Cheshire through clinics (mainly weekly) staffed
by its consultants in every main town in the area. A good liaison exists between the divisions of
Clinical Oncology and Medical Oncology. Many of the clinical protocols are run jointly between the
two departments and there are excellent opportunities at Specialist Registrar level to participate in
joint teaching programmes.
Within the department there are eleven service linear accelerators, a research linac suite, and a
Pantak superficial x-ray therapy unit. There is a purpose built, dedicated Radiotherapy Theatre
housing a high dose rate microselectron. Adjacent to one ward is a low dose rate Selectron remote
afterloading suite. There is a fully equipped Mould Room and facilities are present for interstitial
therapy (including prostate brachytherapy) and manually afterloaded brachytherapy. In 2008
approximately two hundred permanent Iodine one hundred and twenty five seed implants were
conducted. HDR brachytherapy is now in place for prostate patients. There is a large group of
therapeutic radiographers. The Christie is a teaching unit of the University of Liverpool School of
Therapy Radiography.
4.1.2. Haematological Oncology (Director – Dr Mike Dennis)
Dr James Cavet, Dr Adrian Bloor and Dr Mike Dennis run a major transplant unit with 18 dedicated
4.1.3. Other Departments
The Department of Histopathology (Clinical Director – Dr Lia Menasce) provides a regional cancer
The Department of Diagnostic Radiology (Director – Dr Rhidian Bramley) has two whole body spiral
CT scanners and two MR scanners, in addition to standard radiological and radionuclide imaging
facilities. This department is currently undergoing major refurbishment, and will be re-commissioned
with new and more extensive equipment next year. A PET-CT scanner was installed in early 2008.
The Department of Psychological Medicine is involved in collaborative research projects concerning
psychological assessment and counselling in the context of clinical trials and is responsible for staff
training in aspects of psychological support.
4.1.4. Clinical and Laboratory Scientific Research
A wide range of clinical research studies are in progress. The breast, lung and GI research groups
are major contributors to national and international trials of new treatments. These include Phase I/II
and III chemotherapy studies, combined surgery, radiotherapy and chemotherapy studies and patient
evaluation studies (staging procedures, psychological assessment etc). A special interest is taken in
the development of new biological therapies particularly anti-angiogenic therapies (lead by Professor
Gordon Jayson) and gene/immunotherapies (led by Professor Robert Hawkins).
These link laboratory research in the Paterson Institute with early phase clinical trials. The Derek
Crowther Unit was opened in 2003 (lead clinician Dr Malcolm Ranson) and provides excellent clinical
research facilities for early phase clinical trials.
Excellent computer facilities are available within the Medical Oncology Division and there is a close
association with the Department of Medical Statistics. Data managers are in post to help handle
clinical and laboratory research data. Training is given in this important aspect of clinical research.
4.1.5. Administrative facilities
The post holder will have office accommodation with computer, intranet and internet access at both
sites. Similarly there will be secretarial support in line with the provision for the other consultants in the
Directorate. For most consultants this will mean 0.8 – 1 FTE band 4 support with support typing (A&C
band 3) as required.
5. Job Plan:
7.5 DCC (Direct clinical care)
2.5 SPA (Supporting professional activity)
10 PAs Total
DCC includes outpatients, ward rounds, attending MDT meetings including the travel required to
attend these if off-site. The 7.5 PAs DCC includes 1 PA for clinical administration.
SPA includes audit, CPD, teaching research and attendance at Trust committee meetings. Job plans
are reviewed annually. The annual review will examine all aspects of the job plan and should be
carried out jointly by the Clinical Director and the post holder
A nominal allocation of sessions if the appointment is full time is shown below but this will be subject
to change within the limits of the job plan outline above
8-9 am
9 am – 3 pm
Christie Clinic
3-4:30 pm MBC
9 am – 1 pm Christie
Research Clinic
9 am – 1 pm
Christie Clinic
9-10.30 am New
patient meeting
11.30-2 pm – W/R &
MBC meeting
1 – 3 pm MDT SMUHT
2-5 pm Christie Clinic
1-2 pm Grand round
2- 5 pm SPA
The agreed work plan will be subject to annual review in line with Trust policy. This review will also
include an assessment of professional development and defined goals for the future. In the event of
the consultant electing to work part time a pro rata adjustment of fixed sessions would be anticipated.
This will be discussed and agreed with the Division.
Work practice may change over time and this will be reviewed regularly at an annual job plan review
and appraisal. Every effort will be made to ensure that activity levels are kept in line with other
colleagues in the Trust and in line with national benchmarks.
All consultants are associated in pairs where possible within disease groups to provide cross-cover for
The Department has evolved, over many years, a policy of mutual co-operation between the
consultants. The department consultant group meets monthly to discuss joint management policies.
Consultants are grouped in teams of two to six supported by junior staff .The teams accept
responsibility for agreed fields of work and for cover for absence arrangements. All consultants are
expected to co-operate in these arrangements and to be involved in a number of clinical areas of
Clinical Director, Dr M Leahy, chairs the department. The medical oncology department works with the
departments of clinical oncology, young oncology and palliative care as part of the Network Services
Division, chaired by the Divisional Director, (vacant), with Jason Dawson as General Manager.
The post holder will not be required to participate on the on-call rota.
6. Administration
The appointee will be a member of the Department of Medical Oncology Consultant Group. The
appointee will also be a member of The Christie Medical Liaison and Advisory Group.
The Clinical Director within the consultant group negotiates administrative duties within the Clinical
Oncology Department and consultants are expected to accept responsibility for at least one area.
This responsibility is regularly reviewed and can be altered following consultation and agreement with
the Director and colleagues.
7. Particulars of Contract
Any consultant who is unable for personal reasons to work full-time will be eligible to be considered for
the post. The job content will be discussed on a personal basis and agreed with the Trust.
Person Specification
MBBS or equivalent
MRCP or equivalent
Certificate of completion of subspecialty training in Medical
Oncology (or equivalent), or
evidence of completion within 6
months of the date of the
Appointments Committee
Training & Experience
Evidence of wide experience of
general and oncological medicine
Demonstrated interest in teaching /
An interest in teaching medical,
nursing and allied health
professional staff
Experience of teaching
undergraduate / postgraduate
Academic / Research
Able to demonstrate continuing
research interest and activity
Recent articles in peerreviewed publications
MSc, MD or PhD
The ability to initiate design and
supervise clinical research
Personal Skills
Clinical leadership and people
management skills, with the ability
to motivate staff
Demonstrable interpersonal skills
Evidence of excellent written and
oral communication skills
Flexible approach to work
The ability to work as part of as
multi-disciplinary team
Good time management skills, with
the ability to handle competing
Personal Circumstances
Occupational Health Clearance
Enhanced CRB Clearance
Living within reasonable travelling
distance from the trust